Update on Intracerebral Haemorrhage

Overview

Journal J Neurol

Specialty Neurology

Date 2006 May 9

PMID 16680558

Citations 27

Authors

Jose M Ferro

Affiliations

Soon will be listed here.

Abstract

Intracerebral haemorrhage (ICH) is a common and serious disease. About 1 to 2 out of 10 patients with stroke have an ICH. The mortality of ICH is higher than that of ischaemic stroke. Only 31% are functionally independent at 3 months. Only 38% of the patients survive the 1(st) year. The cost of ICH is high. Hypertension is the major risk factor, increasing the risk of ICH about 4x. Up to half of hypertensive patients who suffer a ICH are either unaware of their hypertension, non-compliant with the medication or fail to control periodically their blood pressure levels Microbleeds and white matter changes are MRI markers of the risk of ICH. ICH has 3 main pathophysiological phases: arterial rupture and haematoma formation, haematoma enlargement and peri-haematoma oedema. Up to 40% of the haematomas grow in the first hours post-rupture. ICH growth is associated with early clinical deterioration. Two randomised clinical trials (RCTs) demonstrated that treatment with rFVIIa limited haematoma growth and improved outcome, but was associated with a increase in thromboembolic complications. Ventricular drainage with thrombolytics might improve outcome for patients with intraventricular bleeding. A large RCT and meta-analysis failed to show a benefit of surgery over conservative treatment in acute ICH.

Citing Articles

Delirium and Previous Psychiatric History Independently Predict Poststroke Posttraumatic Stress Disorder.

Griffin T, Bhave V, McNulty J, Christophe B, Garton A, Sander Connolly Jr E Neurologist. 2023; 28(6):362-366.

PMID: 37083500 PMC: 10627542. DOI: 10.1097/NRL.0000000000000495.

Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Shi M, Li X, Zhang T, Tang Q, Peng M, Zhao W Front Neurosci. 2022; 16:825859.

PMID: 35360156 PMC: 8960242. DOI: 10.3389/fnins.2022.825859.

Is an antithrombotic strategy after transcatheter aortic valve implantation clearer now?.

Lv M, Jiang S, Wu T, Chen W, Zhang J J Thromb Thrombolysis. 2021; 52(4):1160-1164.

PMID: 34028670 DOI: 10.1007/s11239-021-02473-9.

Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.

Wu T, Lv C, Wu L, Chen W, Lv M, Jiang S J Neurol. 2021; 269(2):664-675.

PMID: 33594452 DOI: 10.1007/s00415-021-10448-2.

Nontraumatic spontaneous intracerebral hemorrhage: Baseline characteristics and early outcomes.

Al-Khaled M, Awwad S, Bruning T Brain Behav. 2019; 10(1):e01512.

PMID: 31838785 PMC: 6955838. DOI: 10.1002/brb3.1512.

References

Freeman W, Brott T, Barrett K, Castillo P, Deen Jr H, Czervionke L . Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc. 2004; 79(12):1495-500. DOI: 10.4065/79.12.1495. View

Licata B, Turazzi S . Bleeding cerebral neoplasms with symptomatic hematoma. J Neurosurg Sci. 2004; 47(4):201-10. View

Fan Y, Zhang L, Lam W, Mok V, Wong K . Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke. 2003; 34(10):2459-62. DOI: 10.1161/01.STR.0000090841.90286.81. View

Woo D, Sauerbeck L, Kissela B, Khoury J, Szaflarski J, Gebel J . Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002; 33(5):1190-5. DOI: 10.1161/01.str.0000014774.88027.22. View

Eckman M, Rosand J, Knudsen K, Singer D, Greenberg S . Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003; 34(7):1710-6. DOI: 10.1161/01.STR.0000078311.18928.16. View

Schellinger P, Fiebach J, Hoffmann K, Becker K, Orakcioglu B, Kollmar R . Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke. 2003; 34(7):1674-9. DOI: 10.1161/01.STR.0000076010.10696.55. View

. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke. 2005; 36(3):e23-41. DOI: 10.1161/01.STR.0000155685.77775.4c. View

Phan T, Koh M, Wijdicks E . Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol. 2000; 57(12):1710-3. DOI: 10.1001/archneur.57.12.1710. View

Ariesen M, Claus S, Rinkel G, Algra A . Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003; 34(8):2060-5. DOI: 10.1161/01.STR.0000080678.09344.8D. View

10.

Keir S, Wardlaw J, Warlow C . Stroke epidemiology studies have underestimated the frequency of intracerebral haemorrhage. A systematic review of imaging in epidemiological studies. J Neurol. 2002; 249(9):1226-31. DOI: 10.1007/s00415-002-0816-z. View

11.

Friedman J, Ecker R, Piepgras D, Duke D . Cerebellar hemorrhage after spinal surgery: report of two cases and literature review. Neurosurgery. 2002; 50(6):1361-3; discussion 1363-4. DOI: 10.1097/00006123-200206000-00030. View

12.

Naff N, Carhuapoma J, Williams M, Bhardwaj A, Ulatowski J, Bederson J . Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival. Stroke. 2001; 31(4):841-7. DOI: 10.1161/01.str.31.4.841. View

13.

Correia M, Silva M, Matos I, Magalhaes R, Lopes J, Ferro J . Prospective community-based study of stroke in Northern Portugal: incidence and case fatality in rural and urban populations. Stroke. 2004; 35(9):2048-53. DOI: 10.1161/01.STR.0000137606.34301.13. View

14.

Revesz T, Holton J, Lashley T, Plant G, Rostagno A, Ghiso J . Sporadic and familial cerebral amyloid angiopathies. Brain Pathol. 2002; 12(3):343-57. PMC: 8095796. DOI: 10.1111/j.1750-3639.2002.tb00449.x. View

15.

Cantu C, Arauz A, Murillo-Bonilla L, Lopez M, Barinagarrementeria F . Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003; 34(7):1667-72. DOI: 10.1161/01.STR.0000075293.45936.FA. View

16.

Matsuoka H, Hamada R . Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?. CNS Drugs. 2002; 16(8):509-16. DOI: 10.2165/00023210-200216080-00001. View

17.

Kelly J, Hunt B, Lewis R, Rudd A . Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism?. Stroke. 2003; 34(12):2999-3005. DOI: 10.1161/01.STR.0000102561.86835.17. View

18.

Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J . Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis. 2004; 17(2-3):238-41. DOI: 10.1159/000076123. View

19.

Denier C, Labauge P, Brunereau L, Cave-Riant F, Marchelli F, Arnoult M . Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol. 2004; 55(2):213-20. DOI: 10.1002/ana.10804. View

20.

Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel A, Sure U . Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev. 2002; 25(1-2):1-53; discussion 54-5. DOI: 10.1007/s101430100179. View